Skip to main content
Log in

Adamantane-1- and norbornane-2-carboxylic acid hydrazides as HIV inhibitors

  • Search for New Drugs
  • Published:
Pharmaceutical Chemistry Journal Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. S. V. Guzhova, G. I. Danilenko, L. V. Korobchenko, et al.,Fiziol. Aktiv. Veshch.,18, 24–26 (1986).

    CAS  Google Scholar 

  2. Editorial,Rus. Zh. VICH/SPID Rod. Probl. (HIV/AIDS Relat. Probl.),2(3), 8–14 (1998).

  3. I. A. Ryazankin, O. I. Ryazankina, and V. A. Ageenko,Rus. Zh. VICH/SPID Rod. Probl. (HIV/AIDS Relat. Probl.),3(1), 42 (1998).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 34, No. 1, pp. 24–25, January, 2000.

Deceased

Rights and permissions

Reprints and permissions

About this article

Cite this article

Danilenko, G.I., Rybalko, S.L., Maksimov, Y.N. et al. Adamantane-1- and norbornane-2-carboxylic acid hydrazides as HIV inhibitors. Pharm Chem J 34, 23–24 (2000). https://doi.org/10.1007/BF02524553

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02524553

Keywords

Navigation